5 Minute Read
We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
5 Minute Read
We explore the 10 most common challenges facing Market Access operations, based on over 15 years of experience with more than 250 pharma manufacturers.
5 Minute Read
Solutions to common challenges that manufacturers face when commercializing rare and orphan disease therapies.
3 Minute Read
We ask market access leaders what they would change if they had the ability to launch their therapy all over again.